-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
RegMed XB and Inserm signed Memorandum of Understanding
On 2 July 2025, François Alabrune, the French Ambassador to the Netherlands, welcomed Didier Samuel, Chairman and CEO of Inserm, to the French Residence in The Hague for a working visit focused on strengthening scientific collaboration in biomedical research.
read more
Highlights from the RegMed XB 3rd Annual Conference 2025
The 3rd Annual Conference on Regenerative Medicine, hosted by RegMed XB, gathered and attracted nearly 200 attendees. Held on June 18th and 19th in Leuven, Belgium, the event provided a platform for professionals across the entire spectrum of regenerative medicine — from innovative start-ups, researchers, and industry experts to government representatives, health foundations, and visionaries in the field.
read more
From serendipity to startup: the story behind SBMatrices
What began as an accidental discovery in a chemistry lab has evolved into a deeptech venture with the potential to significantly impact organoid research and regenerative medicine.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
